Atrion Corporation (ATRI): Price and Financial Metrics
ATRI Price/Volume Stats
| Current price | $398.68 | 52-week high | $670.00 |
| Prev. close | $399.35 | 52-week low | $274.98 |
| Day low | $395.40 | Volume | 22,200 |
| Day high | $405.58 | Avg. volume | 16,449 |
| 50-day MA | $395.57 | Dividend yield | 2.2% |
| 200-day MA | $409.78 | Market Cap | 701.68M |
ATRI Stock Price Chart Interactive Chart >
Atrion Corporation (ATRI) Company Bio
Atrion Corporation develops, manufactures, and sells fluid delivery devices, and ophthalmic and cardiovascular products for medical applications primarily in the United States, Canada, and internationally. The company was founded in 1944 and is based in Allen, Texas.
Latest ATRI News From Around the Web
Below are the latest news stories about ATRION CORP that investors may wish to consider to help them evaluate ATRI as an investment opportunity.
Insider Buying: Atrion President & CEO Bought US$90k Of SharesWhilst it may not be a huge deal, we thought it was good to see that the Atrion Corporation ( NASDAQ:ATRI ) President... |
Atrion Reports Third Quarter 2023 ResultsALLEN, Texas, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the third quarter ended September 30, 2023. Revenues for the third quarter of 2023 totaled $41.9 million compared to $44.6 million for the same period in 2022. For the quarter ended September 30, 2023, operating income was $4.1 million, down $5.5 million from the comparable 2022 period, and net income was $2.9 million, down $5.9 million from the same period in 2022. Third quarter 202 |
Returns On Capital At Atrion (NASDAQ:ATRI) Paint A Concerning PictureIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Typically, we'll want to notice a... |
Atrion Corporation Announces Election of New DirectorALLEN, Texas, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) announced the election today of Jeannette Bankes as a director, effective immediately. Ms. Bankes brings to our Board over 32 years of experience at major medical device and pharmaceutical companies. Since March 2019, Ms. Bankes has served as the President and General Manager of the Global Surgical Franchise at Alcon Inc. From August 2004 to March 2019, Ms. Bankes served in leadership positions across multiple div |
Atrion Corporation's (NASDAQ:ATRI) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?With its stock down 17% over the past three months, it is easy to disregard Atrion (NASDAQ:ATRI). However, the... |
ATRI Price Returns
| 1-mo | -8.58% |
| 3-mo | 29.99% |
| 6-mo | 13.73% |
| 1-year | -35.18% |
| 3-year | -37.64% |
| 5-year | -51.07% |
| YTD | 5.80% |
| 2023 | -30.92% |
| 2022 | -19.58% |
| 2021 | 10.94% |
| 2020 | -13.63% |
| 2019 | 2.16% |
ATRI Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Continue Researching ATRI
Want to do more research on Atrion Corp's stock and its price? Try the links below:Atrion Corp (ATRI) Stock Price | Nasdaq
Atrion Corp (ATRI) Stock Quote, History and News - Yahoo Finance
Atrion Corp (ATRI) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...